Notice2026-05906
Notice Pursuant to the National Cooperative Research and Production Act of 1993-Biopharmaceutical Manufacturing Preparedness Consortium
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 26, 2026
Issuing agencies
Justice DepartmentAntitrust Division
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 58 (Thursday, March 26, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 58 (Thursday, March 26, 2026)]
[Notices]
[Pages 14715-14716]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-05906]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Biopharmaceutical Manufacturing Preparedness
Consortium
Notice is hereby given that, on October 8, 2025, pursuant to
section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), Biopharmaceutical
Manufacturing Preparedness Consortium (``BIOMAP-CONSORTIUM'') has filed
written notifications simultaneously with the Attorney General and the
Federal Trade Commission disclosing changes in its membership. The
notifications were filed for the purpose of extending the Act's
provisions limiting the recovery of antitrust plaintiffs to actual
damages under specified circumstances. Specifically, AGC Biologics,
Bothell, WA; Anavatos Bio, Inc., Seattle, WA; Cidara Therapeutics INC,
San Diego, CA; Crossmhv, L.l.C, Tampa, FL; Defense Operations &
Execution Solutions INC, W Melbourne, FL; Health Supply US LLC,
Mooresville, NC; Nanopass Technologies Ltd., Nes Ziona, STATE OF
ISRAEL; Ommio Health, INC, Woodbridge, CT; UI Pharmaceuticals, Iowa
City, IA; Axelyf, Inc., Chestnut Hill, MA; BetteRx Compounding Inc.,
Smithfield, RI; Crossject SA, Dijon, FRENCH REPUBLIC; Lavik Consulting
LLC, Oakland, MO; Nanotag Biotechnologies Gmbh, Goettingen, FEDERAL
REPUBLIC OF GERMANY; Quality Assured Artificial Intelligence LLC, Green
Cove Springs, FL; Award Advisors, Washington, DC; Beckman Research
Institute of the City of Hope, Duarte, CA; Gemini Therapeutics, San
Fransisco, CA; Lumacyte, INC, Charlottesville, VA; Modus Operandi,
[[Page 14716]]
Inc., Melbourne, FL; Ship Odyssey, Inc., Sevierville, TN; Synergistic
INC, New Baltimore, MI; Occam Systems Incorporated, Glen Allen, VA;
Renco Manufacturing Group INC, Colebrook, NH; Revolution
Biomanufacturing INC, Canton, MA; Sagitta Biotech, Li[egrave]ge,
KINGDOM OF BELGIUM; Argentum Pharmaceuticals LLC, Aspen, CO; Culmen
International, LLC, Alexandria, VA; EXCITE PHARMA SERVICES, LLC, Lees
Summit, MO; Johns Hopkins Center for Health Security, Baltimore, MD;
KNIGHT GREGORIAN, INC., Vista, CA; Kensington Street Consulting LLC,
Arlington, VA; Method Made, Montreal, CANADA; Mriglobal, Kansas City,
MO; N! Biomachines Ltd., Burlington, ON; Safi Biotherapeutics INC,
Cambridge, MA; Science Systems and Applications, Inc., Lanham, MD; True
Diagnostics, Inc., Carlsbad, CA; and Zeteo Biomedical LLC, Austin, TX
have been added as parties to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and the BIOMAP-CONSORTIUM intends to
file additional written notifications disclosing all changes in
membership.
On January 5, 2024, the BIOMAP-CONSORTIUM filed its original
notification pursuant to section 6(a) of the Act. The Department of
Justice published a notice in the Federal Register pursuant to section
6(b) of the Act on April 16, 2024 (89 FR 26923).
The last notification was filed with the Department on July 24,
2025. A notice was published in the Federal Register pursuant to
section 6(b) of the Act on January 20, 2026 (91 FR 2369).
Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2026-05906 Filed 3-25-26; 8:45 am]
BILLING CODE P
</pre></body>
</html>Indexed from Federal Register on March 26, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.